Clinical Trial Update: The Effect of Therapy Combination in PCOS With Dlbs 3233 [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluating a therapy combination including Dlbs 3233 for Polycystic Ovary Syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Dlbs 3233

Snippet

Sponsor: Inlacinpenelitian | Conditions: Polycystic Ovary Syndrome | EARLY_Phase 1 | Status: RECRUITING